Hadassah

Spotlight on Hadassah's Dr. Yuval Gielchinsky: Specialist in Fetal Medicine

Monday, Sep 12 2011

Dr. Yuval Gielchinsky, an obstetrician with a PhD in molecular biology, is a specialist in Fetal Medicine at the Hadassah University Medical Center, who honed his knowledge and skills during a two-and-half-year fellowship with the founder of the first Fetal Medicine Unit in the United Kingdom at King's College in London, Prof. Kypros Nicolaides.

Now back at Hadassah, Dr. Gielchinsky has begun establishing a Fetal Medicine Unit at the Medical Center. Unlike the current practice of regarding maternal and fetal medicine as a single entity, this relatively new multidisciplinary field of fetal medicine focuses solely on the baby in the womb, Dr. Gielchinsky explains.

Dr. Gielchinsky has already altered conventional screening strategies, instituting first trimester screening--involving ultrasound and chromosome identification--to identify problems and anomalies during the 12th week of growth. He has introduced endoscopic examination of the womb to provide additional information on the baby's condition. If the endoscopy reveals a problem, he can then intervene, as appropriate. Operating on a fetus in the womb, Dr. Gielchinsky is able to correct developmental abnormalities, ensuring, for example, that twins each have an individual source of blood.

Before he left for London, Dr. Gielchinsky was the Principle Investigator of the Hadassah-Hebrew University research team which made the groundbreaking discovery that pregnancy restores liver regeneration in aged mice. The implications of this finding created international interest since the discovery could eventually be relevant to other tissues and organs and lead to the ability to stimulate their regeneration.

Dr. Gielchinsky believes that "Hadassah is strong enough to set the example" and can lead the way in creating new policies in Israel for better care of babies while still in the womb.

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Wednesday, Aug 16 2017

Gazan Boy Walks for First Time at Hadassah

Unable to stand on his feet, suffering from severe respiratory distress, a four-year-old boy from Gaza gained the ability to walk once Hadassah Hospital surgeons identified and removed a large tumor lodged in his chest.

READ MORE ›
alt_text

Wednesday, Aug 16 2017

Hadassah Hosts Health Innovation Conference

Over one hundred doctors, researchers, and entrepreneurs gathered at Hadassah Hospital Ein Kerem this summer to discuss how to advance the quality of patient care with computational power.

READ MORE ›
alt_text

Monday, Aug 14 2017

Hadassah Hosts First Human Trial with Drug to Fight Nasty Bacterial Infection

Immuron, an Australian biopharmaceutical company, has received approval from the Hadassah Medical Organization’s ethics committee and Israel’s Ministry of Health to begin its first clinical trial with a new drug to fight a bacterial infection called Clostridium Difficile (CDI).

READ MORE ›
alt_text

Thursday, Aug 3 2017

Mystery of Devastating Pediatric Disease Solved by Hadassah Team

A genetic mutation causing a rare and devastating pediatric neurological disease that has puzzled medical centers around the world has been identified at the Hadassah Medical Organization by Prof. Orly Elpeleg, head of Hadassah's Department of Genetics and Metabolic Diseases.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More